Chronic intestinal decontamination with rifaximin, non-absorbed gut-directed antibiotic, decreases the severity of acute kidney injury and HRS by reducing serum TNFα levels in patients with advanced cirrhosis [16]. The gene discussed is TNF; the disease is acute kidney injury.